A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Interventional Study of Vosoritide for the Treatment of Children with Hypochondroplasia

A Multicenter Multinational Observational Study of Children With Hypochondroplasia